The Use of Heparin for Preventing Miscarriage

American Journal of Reproductive Immunology

Volumn 67, Issue 4, 2012, Pages 326-333

  Check, Jerome H ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Antiphospholipid syndrome; Heparin; Inherited thrombophilias; Miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENOXAPARIN; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PROSTACYCLIN; PROTEIN C; THROMBOXANE A2; VASCULAR CELL ADHESION MOLECULE 1;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; CELL PROTECTION; CLINICAL DECISION MAKING; DRUG MEGADOSE; FIBRINOLYSIS; GENETIC DISORDER; HEMOSTASIS; HUMAN; LIVE BIRTH; NONHUMAN; PLACENTA DISORDER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECURRENT ABORTION; REVIEW; SPONTANEOUS ABORTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPOIESIS; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT DURATION; TROPHOBLAST; VASOCONSTRICTION;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ANTIBODIES, PHOSPHO-SPECIFIC; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HEPARIN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA;

EID: 84858705331     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01119.x     Document Type: Review

References (58)

1. Hughes GR: Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J 1983; 287:1088-1089.
2. Lockshin MD: Antiphospholipid antibody. Babies, blood clots, biology. JAMA 1997; 277:1549-1551.
3. Kaider AS, Kaider BD, Janowicz PB, Roussev RG: Immunodiagnostic evaluation in women with reproductive failure. Am J Reprod Immunol 1999; 42:335-346.
4. Cuadrado MJ, Lopez-Pedrera C, Khamashta MA, Camps MT, Tinahones F, Torres A, Hughes GR, Velasco F: Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997; 40:834-841.
5. Reverter JC, Tassies D, Font J, Khamashta MA, Ichikawa K, Cervera R, Escolar G, Hughes GR, Ingelmo M, Ordinas A: Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum 1998; 41:1420-1427.
6. Forastiero RR, Martinuzzo ME, Broze GJ: High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome. J Thromb Haemost 2003; 1:718-724.
7. Meroni PL, Raschi E, Camera M, Testoni C, Nicoletti F, Tincani A, Khamashta MA, Balestrieri G, Tremoli E, Hess DC: Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestation of the syndrome. J Autoimmun 2000; 15:237-240.
8. Lellouche F, Martinuzzo M, Said P, Maclouf J, Carreras LO: Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 1991; 78:2894-2899.
9. Carreras LO, Vermylen JG: "Lupus" anticoagulant and thrombosis - possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48:38-40.
10. Girardi G: Heparin treatment in pregnancy loss: potential therapeutic benefits beyond anticoagulation. J Reprod Immunol 2005; 66:45-51.
11. Van Horn JT, Craven C, Ward K, Branch DW, Silver RM: Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004; 25:642-648.
12. Di Simone N, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A: Low-molecular weight heparin restores in vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999; 14:489-495.
13. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112:1644-1654.
14. McIntyre JA: Antiphospholipid antibodies in implantation failures. Am J Reprod Immunol 2003; 49:221-229.
15. American College of Obstetrics and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 118: antiphospholipid syndrome. Obstet Gynecol 2011;117:192-199.
16. Tebo AE, Jaskowski TD, Phansalkar AR, Litwin CM, Branch DW, Hill HR: Diagnostic performance of phospholipid - specific assays for the evaluation of antiphospholipid syndrome. Am J Clin Pathol 2008; 129:870-875.
17. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC: The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369-373.
18. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS: Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993; 100:909-913.
19. Many A, Schreiber I, Rosner S, Lessing JB, Eldor A, Kupferminc MJ: Pathological features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001; 98:1041-1044.
20. Mousa HA, Alfirevic Z: Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000; 15:1830-1833.
21. Lyden TW, Vogt E, Ng AK, Johnson PM, Rote NS: Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 1992; 22:1-14.
22. Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H: Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 2006; 107:3173-3180.
23. Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L, Huppertz B: Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 2005; 192:23-30.
24. Tulppala M, Marttunen M, Soderstrom-Anttila V, Foudila T, Ailus K, Palosuo T, Ylikorkala O: Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997; 12:1567-1572.
25. Mak A, Cheung MW, Cheak AA, Ho RC: Combination of heparin and aspirin is superior to aspirin alone inenhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology 2010; 49:281-288.
26. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
27. Empson MB, Lassere M, Craig JC, Scott JR: Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002; 99:135-144.
28. Empson MB, Lassere M, Craig JC, Scott JR: Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005; 18:CD002859.
29. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361:901-908.
30. Dudding TE, Attia J: The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 91:700-711.
31. Lissalde-Lavigne G, Fabbro-Peray P, Cochery-Nouvellon E, Mercier E, Ripart-Neveu S, Balducchi JP, Daures JP, Pernegar T, Quere I, Dauzat M, Mares P, Gris JC: Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control "NOHA first" study. J Thromb Haemost 2005; 3:2178-2184.(Level II-2).
32. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, Fonjtcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, van der Meer FJ: Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348:913-916.
33. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel Jr G, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ, Gabbe SG: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: The relationship of the factor V leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106:517-524.
34. Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G Jr, Wenstrom K, Samuels P, Caritis SN, Sorokin Y, Miodovnik M, O'Sullivan MJ, Conway D, Wapner RJ: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (NICHD MFMU) Network: Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010; 115:14-20.(Level II).
35. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskesk TK: Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74:1196-1199.
36. Krabbendam I, Franx A, Bots ML, Fijnheer R, Bruinse HW: Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 2005; 118:143-153.
37. Lockwood C, Wendel G: Committee on practice bulletins - obstetrics. Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstet Gynecol 2011; 118:730-740.
38. Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR: The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod 1994; 9:1954-1957.
39. Check JH, Dietterich C, Lurie D, Nazari A, Choung J: A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. J Assist Reprod Genet 1998; 15:579-582.
40. Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, Whyte S, Greer IA: SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115:4162-4167.
41. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S: Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2009; 21:CD004734.
42. Kaandorp SP, Goddijn M, van derPost JA, Hutten BA, Verhoeve HR, Hamulyak K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DN, Buller HR, van derVeen F, Middeldorp S: Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Eng J Med 2010; 362:1586-1596.
43. Wagenknecht DR, McIntyre JA: Interaction of heparin with beta 2-glycoprotein I and antiphospholipid in vitro. Thromb Res 1992; 68:495-500.
44. Chamley LW: Antiphospholipid antibodies: biological basis and prospective for treatment. J Reprod Immunol 2002; 57:185-202.
45. Franklin RD, Kutteh WH: Effects of unfractionated and low molecular weight heparin in antiphospholipid antibody binding in vitro. Obstet Gynecol 2003; 101:455-462.
46. Di Simone W, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A: Low- molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999; 14:489-495.
47. Rent R, Myhrman R, Fiedel BA, Gewz H: Potentiation of C1-esterase inhibitory activity by heparin. Clin Exp Immunol 1976; 23:264-271.
48. Weiler J, Yurt RW, Fearon DT, Austen KF: Modulation of the formation of the amplification convertase of complement C3b, Bb, by native and commercial heparin. J Exp Med 1978; 147:409-421.
49. Ninomiya H, Kawashima Y, Nagasawa T: Inhibition of complement mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin. Br J Haematol 2000; 109:875-881.
50. Girardi G, Redecha P, Salmon JE: Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10:1222-1226.
51. Noble LS, Kutteh WH, Laghey N, Franklin RD, Herrada J: Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low molecular weight heparin versus unfractionated heparin. Fertil Steril 2005; 83:684-690.
52. Greer IA, Nelson-Piercy C: Low-molecular weight heparins for thromboprophylaxis and treatment of various thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106:401-407.
53. Happe LE, Farrelly EM, Stanford RH, Sarnes MW: Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries. J Throm thrombolysis 2008; 26:125-131.
54. Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R: Excretion of low molecular weight heparin in human milk. Br J Clin Pharrmacol 2001; 52:708-710.
55. Clark SL, Porter TF, West FG: Coumarin derivatives and breast feeing. Obstet Gynecol 2000; 95:938-940.
56. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA: Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study: Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132:171-196. (meta-analysis).
57. Kosmas IP, Tatsioni A, Ioannidis JP: Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta analysis. J Hypertens 2003; 21:1221-1228.
58. Check JH: A practical approach to the prevention of miscarriage: Part 1 - progesterone therapy. Clin Exp Obst Gyn 2009; 36:203-208.